PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION
El-Mahdy, M., Hassan, A., El-Badry, M., El-Gindy, G. (2020). PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION. EKB Journal Management System, 43(1), 105-122. doi: 10.21608/bfsa.2020.93599
Mona M. El-Mahdy; Abeer S. Hassan; Mahmoud El-Badry; Gamal El-Din A. El-Gindy. "PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION". EKB Journal Management System, 43, 1, 2020, 105-122. doi: 10.21608/bfsa.2020.93599
El-Mahdy, M., Hassan, A., El-Badry, M., El-Gindy, G. (2020). 'PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION', EKB Journal Management System, 43(1), pp. 105-122. doi: 10.21608/bfsa.2020.93599
El-Mahdy, M., Hassan, A., El-Badry, M., El-Gindy, G. PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION. EKB Journal Management System, 2020; 43(1): 105-122. doi: 10.21608/bfsa.2020.93599

PERFORMANCE OF CURCUMIN IN NANOSIZED CARRIERS NIOSOMES AND ETHOSOMES AS POTENTIAL ANTI-INFLAMMATORY DELIVERY SYSTEM FOR TOPICAL APPLICATION

Bulletin of Pharmaceutical Sciences Assiut University
Article 9, Volume 43, Issue 1, June 2020, Page 105-122  XML PDF (2.28 MB)
Document Type: Original Article
DOI: 10.21608/bfsa.2020.93599
View on SCiNiTO View on SCiNiTO
Authors
Mona M. El-Mahdy1; Abeer S. Hassan2; Mahmoud El-Badry3; Gamal El-Din A. El-Gindy1
1Department of Pharmaceutics, Faculty of Pharmacy, Assiut University. Assiut 71526, Egypt
2Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt
3Department of Pharmaceutics, Faculty of Pharmacy, Assiut University. Assiut 71526, Egypt & Assiut International Center of Nanomedicine, Al-Rajhy Liver Hospital, Assiut University, Assiut 71515, Egypt
Abstract
Curcumin (CUR) is one of the most commonly used herbal product; it shows effective anti-inflammatory and anti-oxidant effects. However, poor aqueous solubility and low permeability are the major challenges in therapeutic application of curcumin. One class of vesicular nanocarriers called “Niosome and ethosome” which have proved to possess distinct advantages were used to encapsulate curcumin and evaluated for their morphology, particle size, zeta potential, entrapment efficiency (EE%) and drug release. They were incorporated into hydroxy propyl methyl cellulose (HPMC15000) gel then, evaluated on the rat skin via inhibition of carrageenan induced rat paw edema. The results showed that the particle size of curcumin loaded niosomes and ethosomes were ranged (317.5±1.91 to 558.3±8.587 nm) and (182.1±5.3 to 354.5±30.03 nm), respectively. Skin permeation studies demonstrated that CUR permeability coefficient through rat kin for gel formulations of loaded vesicles was ~ four times higher as compared to free CUR. The in-vivo anti-inflammatory studies proved that gel formulations of CUR vesicles possessed higher significant inhibition of carrageenan induced rat paw edema when compared to pure curcumin. Accordingly, the results revealed that, curcumin loaded nanovesicels held great potential approaches as anti-inflammatory in topical application.
Statistics
Article View: 1,227
PDF Download: 1,084